FDA Investigator Pankaj H Amin

Pankaj H Amin has inspections in 10 countries as of 29 Sep 2023. Pankaj H Amin has collaborated with a combinined 5279 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
48
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India, United States of America, Denmark, Belgium, France, Austria, Israel, Australia, Germany, Sweden
Co-Investigator(s):
Alan L Truong, Alan P Kurtzberg, Alberto A Viciedo, Albinus D'sa, PhD, Albinus M D Sa, Alicia M Mozzachio, Anastasia M Shields, Andrey Sarafanov, PhD, Angela E Glenn, Anissa M Cheung, Ann L Demarco, Ann M Stewart, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Anthony J Ladner, Arie C Menachem, Arthur S Williams, Jr, Ashley J Burns, Azza Talaat, Barbara L Rogolsky, Ben A Firschein, Bharat Khurana, Bo Chi, PhD, Bonita S Chester, Bradley Dworak, PhD, Brenda W Uratani, PhD, Burnell M Henry, Candace Y Gomez Broughton, Carolyn Yong, PhD, Carrie A Hughes, CDR Cecily Jones, CDR Jeremy L Wally, PhD, Charanjeet Jassal, Charles D Brown, Charles M Edwards, Cheryl A Clausen, Christian D Lynch (CDL), Christopher S Keating, Claire M Minden, Constantin Y Philopoulos, Cynthia Jim, CSO, Cynthia Kelley, Dale A Nyberg, Daniel C Kearns, Daniel J Roberts, Darren S Brown, David Galler Veety, Deborah M Trout, Denise L Burosh, Dennis Cantellops Paite, Dino Feigelstock (DF), PhD, Dipesh K Shah, Dmitriy V Volokhov, PhD, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Douglas A Campbell, Dr. Carmelo Rosa, Dr. Gang Wang, PhD, Dr. Gopa Biswas, PhD, Dr. Robert C Horan, MD, Dr. Willie F Vann, PhD, Eileen A Liu, Ellen Huang, Ellen P Madigan, Emmanuel J Ramos, Erika V Butler, Erin C Hill, Ewa Marszal, PhD, Farhana Khan, Felix Maldonado, Freddy Ortiz Colon, Frederick Razzaghi, Gene D Arcy, George Pyramides, Gwyn G Dickinson, Haitao Li, Haruhiko Murata, Hector A Carrero, Helen B Ricalde, Holly Brevig, Irina Gaberman, Ivy E Sweeney, J David Doleski, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James C Maclaughlin, James L Dunnie, Jr, James R Evans, Jaqueline Diaz Albertini, Jason K Morgan, Javier O Vega, Jawaid Hamid, Jay V Jariwala, Jean Lhu Primmer, Jeanne J Thai, Jennifer L Reed, Jessica L Pressley, Jie He, Joan A Loreng, Joan Johnson, Joan M Cantellops Figueroa, Joanne E King, Joanne M Schlossin, Jogy George, John F Cipollo, John M Mcinnis, John S Hartford, John Stansberry, PhD, Jolanna A Norton, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Joseph George, June P Page, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Kara D Dobbin, Karen E D'orazio, Karen K Moksnes, Karen Takahashi, Katherine Szestypalow, Kellia N Hicks, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kirsten L Vadheim, PhD, Kirsten L Vodheim, PhD, L Norwood, Larry K Austin, Lata C Mathew, PhD, Laurel A Beer, Laurie B Frazier, Laurie Graham, Laurie P Norwood, LCDR Debra Emerson, Leslie D Wagner, Liming Zhang, Linda F Murphy, Linda R Kuchenthal, Linda Thai, Lisa M Parsons, Lori A Carr, Lori A Holmquist, LTJG Bradley E Benasutti, Lu Deng, Luis A Dasta, Lydia Irosas Marty, M Pedgen, Makini Cobourne Duval, PhD, Malgorzata G Norton, Maria Estrella, Marian Majors, Marion Michaelis, Mariza M Jafary, Marlene G Swider, Marvin D Jones, Mary E Farbman, PhD, Mary Jeanet Mcgarry, Maryna C Eichelberger, PhD, Massoud Motamed, Matthew B Casale, Megan A Haggerty, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael A Taylor, Michael C Kennedy, PhD, Michael G Sinkevich, Michael J Vardon, Michael L Chasey, Michael R Goga, Michele L Forster, PhD, Michele Perry Williams, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Mohsen Rajabi Abhari, FDA, Mra Davism, Muralidhara B Gavini, PhD, Muralidhara D Givani, Nadeem I Chaudhry, Nancy Kirschbaum, PhD, Nancy L Neiger, Nancy M Espinal, Nawab A Siddiqui, Nayan J Patel, Nicole E Knowlton, Nutan Mytle, Obinna R Echeozo, Olga Simakova, Olno Folgolstock, Omotunde O Osunsanmi, Parul M Patel, Patricia Fhughes Troost, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul A Bonneau, Paul D Keller, Paul W Keller, Paula A Trost, Penny H Mccarver, Pete Amin (Pankaj), Peter E Baker, Pote Amin, Prabhu P Raju, Prajakta A Varadkar, Pratik S Upadhyay, DDC, Priscilla M Pastrana, Rajiv R Srivastava, Ralph A Erickson, Ramon E Martinez, Randa Melhem, PhD, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca K Olin, Regina T Brown, Richard E Needham, Richard H Penta, Richard W Berning, Richard W Thornton, Robert D Tollefsen, Robert J Martin, Robert W Jennings, Robin Levis, PhD, Rochelle L Cross, Roger F Zabinski, Rose M Ashley, Saleem A Akhtar, Samina S Khan, Sangeeta M Khurana, PhD, Sanket N Patel, Santos E Camara, Sarah B Tanksley, Scott B Laufenberg, Scott E Norris, Scott R Nichols, PhD, Scott T Ballard, Sean R Bryd, Sean R Marcsisin, Sharon K Thoma, PharmD, Sherry G Bous, Shirshendu K Deb, PhD, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Stacey S Degarmo, Stephen D Eich, Steven A Rubin, Steven C Madzo, Susan M Jackson, Susant Hadman, Swati Verma, Tamil Arasu, PhD, Terrig Thomas, PhD, Thai D Truong, Thomas J Arista, Timothy M Martin, Timothy T Kapsala, Tina S Roecklein, Tomika L Bivens, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Travis S Bradley, Tricia S Martinez, Unnee Ranjan, Victoria A Wagoner, Vioela J Caze, Viviana Matta, Viviana R Ramirez, Walden H Lee, Wayne E Seifert, William A Warnick, Xianghong Jing (Emily), PhD, Xiao Wang, Xikui Chen (nmi), PhD, Yonggang Wang, PhD, Yuanyuan Li, Yumi J Hiramine, Ze Peng, Zhaoyang Meng, Zhihao Qiu (Peter), PhD

Pankaj H Amin's Documents

Publish Date Document Type Title
December, 2007 FDA 483 Response GlaxoSmithKline Biologicals SA - Form 483R, 2008-01-17
April, 2004 FDA 483 Response Sanofi Pasteur - Form 483R, 2004-05-27
December, 2007 EIR GlaxoSmithKline Biologicals SA - EIR, 2008-03-25
June, 2010 EIR BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED - EIR, 2010-06-16
March, 2012 FDA 483 GSK Vaccines GmbH - Form 483, 2012-03-27
April, 2004 EIR Sanofi Pasteur - EIR, 2004-04-30
March, 2019 EIR IDT Biologika GmbH - EIR, 2019-03-08
April, 2004 FDA 483 Aventis Pasteur SA - Form 483, 2004-04-30
June, 2010 FDA 483 BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED - Form 483, 2010-06-16
November, 2010 FDA 483 Emcure Pharmaceuticals Limited - Form 483, 2010-11-22
February, 2010 FDA 483 LUPIN LIMITED - Form 483, 2010-02-12
April, 2009 FDA 483 Micro Labs Limited - Form 483, 2009-04-17
August, 2010 EIR Gufic Bioscience Limited - EIR, 2010-08-28
January, 2009 FDA 483 Suven Pharmaceuticals Limited - Form 483, 2009-01-07
May, 2016 EIR Vericel Corporation - EIR, 2016-05-13
December, 2007 FDA 483 GlaxoSmithKline Biologicals SA - Form 483, 2007-12-13
October, 2021 FDA 483 Lonza Biologics, Inc. - Form 483, 2021-10-22
March, 2019 FDA 483 Response IDT Biologika GmbH - Form 483R, 2019-03-25
December, 2009 EIR Cadila Pharmaceuticals Limited - EIR, 2009-12-11
December, 2009 FDA 483 Arch Pharmalabs Limited - Form 483, 2009-12-05
June, 2010 FDA 483 Response BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED - Form 483R, 2010-06-16
April, 2017 FDA 483 Kamada - Production Plant - Form 483, 2017-04-05
March, 2019 FDA 483 IDT Biologika GmbH - Form 483, 2019-03-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more